Risk Stratification in Acute Exacerbation of COPD: Interview with Dr. Andrew Shorr, BAP-65 Score Creator

Dr. Andrew Shorr (headshot)

Dr. Andrew Shorr

Andrew Shorr, MD, MPH, is an associate director of pulmonary and critical care medicine and the chief of the Pulmonary Clinic at MedStar Washington Hospital Center in Washington, DC. Dr. Shorr’s research interests include resistant pathogens and healthcare-associated bacteremia, and he has published more than 140 original studies.

Why did you develop the BAP-65 Score? Was there a particular clinical experience or patient encounter that inspired you to create this tool for clinicians?

I think we were interested in developing the score for two reasons: one, as a purely academic exercises, given that we have risk scores for PE and risk scores for pneumonia, clearly one of the pulmonary disease states where patients are sicker than they look is in COPD. So it was a clear hole in the range of pulmonary-critical care disease states that didn’t have some pulmonary risk stratification tool. And when you tie that together with the fact that COPD is a leading reason for admission in general, you can understand.

Continue reading “Risk Stratification in Acute Exacerbation of COPD: Interview with Dr. Andrew Shorr, BAP-65 Score Creator”